Literature DB >> 2576144

Nicotine-induced tail-tremor and drug effects.

Y Gomita1, K Suemaru, K Furuno, Y Araki.   

Abstract

Tail-tremor induced by repeated and daily administration (0.5 mg/kg SC x 6 times/day) of nicotine as well as effects of various drugs on this response were investigated in Wistar strain male rats. Daily administration of nicotine in doses of 0.5 mg/kg SC caused tail-tremors to appear beginning on the 3rd day. Tail-tremor induced by the first injection of each day gradually increased with the daily injections, however, the heightened effect of this first injection at the beginning of each day decreased during the day upon repeated administration of 6 times/day at 2-hr intervals. Basically, tail-tremor appeared about 5 min after SC administration of nicotine and reached a peak approximately 7-9 min after injection, declining to zero afterwards. Different drugs showed various effects on this response. While mecamylamine (0.5 and 1.0 mg/kg IP) abolished nicotine-induced tail-tremor, arecoline (0.5 and 1.0 mg/kg IP), atropine (2.5 and 5.0 mg/kg IP), scopolamine (1.0 and 2.0 mg/kg IP) and hexamethonium (0.5 and 1.0 mg/kg IP) showed no such effects. Furthermore, physostigmine (0.1 mg/kg IP) actually potentiated this action. These results suggest that tail-tremor induced by nicotine may be mediated through central nicotine receptor system.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2576144     DOI: 10.1016/0091-3057(89)90280-3

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  6 in total

1.  Neuropsychological function in manganese alloy plant workers.

Authors:  Rita Bast-Pettersen; Dag G Ellingsen; Siri M Hetland; Yngvar Thomassen
Journal:  Int Arch Occup Environ Health       Date:  2004-03-13       Impact factor: 3.015

2.  Mechanism Underlying Organophosphate Paraoxon-Induced Kinetic Tremor.

Authors:  Higor Alves Iha; Naofumi Kunisawa; Saki Shimizu; Misaki Onishi; Yuji Nomura; Nami Matsubara; Chihiro Iwai; Mizuki Ogawa; Mai Hashimura; Kazuaki Sato; Masaki Kato; Yukihiro Ohno
Journal:  Neurotox Res       Date:  2019-02-07       Impact factor: 3.911

3.  Characteristics of tail-tremor induced by nicotine in rats.

Authors:  K Suemaru; R Oishi; Y Gomita
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-08       Impact factor: 3.000

4.  The nicotinic antagonist mecamylamine precipitates nicotine abstinence syndrome in the rat.

Authors:  D H Malin; J R Lake; V A Carter; J S Cunningham; K M Hebert; D L Conrad; O B Wilson
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530

5.  Nicotine Elicits Convulsive Seizures by Activating Amygdalar Neurons.

Authors:  Higor A Iha; Naofumi Kunisawa; Saki Shimizu; Kentaro Tokudome; Takahiro Mukai; Masato Kinboshi; Akio Ikeda; Hidefumi Ito; Tadao Serikawa; Yukihiro Ohno
Journal:  Front Pharmacol       Date:  2017-02-09       Impact factor: 5.810

Review 6.  The role of NMDA receptor antagonists in nicotine tolerance, sensitization, and physical dependence: a preclinical review.

Authors:  Raka Jain; Kaushiki Mukherjee; Yatan Pal Singh Balhara
Journal:  Yonsei Med J       Date:  2008-04-30       Impact factor: 2.759

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.